Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 928
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
for
Small Cell Lung Cancer
Location: Portland OR, Aurora CO, Milwaukee WI, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780137
Phase 1, Phase 2, Recruiting
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
for
Grade 3b Follicular Lymphoma, High Grade B-Cell Lymphoma,
Location: Portland OR, Oregon City OR, Newberg OR,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05890352
Phase 2, Recruiting
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
for
NSCLC, Stage I
Location: Portland OR, Omaha NE, Minneapolis MN, Iowa City IA,
Sponsor: Greg Durm, MD
Sex: All
Age: 18+
Code: NCT04317534
Phase 2, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Portland OR, Oregon City OR, Newberg OR, Duarte CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase 3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Portland OR, Tacoma WA, Vancouver, Roseville CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase 3, Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Portland OR, Vancouver, Duarte CA, Corona CA, Winnipeg,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase 3, Recruiting
Endolumenal Partial Myotomy for Esophageal Motility Disorders
for
Esophageal Motility Disorders
Location: Portland OR
Sponsor: The Oregon Clinic
Sex: All
Age: 18 - 70+
Code: NCT01302301
Phase 2, Recruiting
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
for
Small Cell Lung Cancer (SCLC),
Location: Portland OR, Seattle WA, Duarte CA, Los Angeles CA,
Sponsor: Phanes Therapeutics
Sex: All
Age: 18+
Code: NCT05652686
Phase 1, Phase 2, Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
for
Advanced Colorectal Carcinoma,
Location: Portland OR, Vancouver WA, Oregon City OR, Newberg OR,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06073431
Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
for
Advanced Extrapulmonary Neuroendocrine Carcinoma,
Location: Portland OR, Oregon City OR, Newberg OR, Bend OR,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05058651
Phase 2, Phase 3, Recruiting
Study of the Shockwave Medical SkyRunner Carotid Intravascular Lithotripsy (IVL) System for the Treatment of Calcified Carotid Arteries Prior to Trans-Carotid Stenting (SKYWARD Trans-Carotid IDE [Investigational Device Exemption] Study)
Location: Portland OR, San Francisco CA, Rancho Mirage CA,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT07062471
Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: Portland OR, Seattle WA, Roseville CA, Sacramento CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase 3, Recruiting
Family Communications After Genetic Testing
for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Portland OR, Clackamas OR, Vancouver WA, Oregon City OR,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07143487
Recruiting
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Location: Portland OR, Seattle WA, Edmonds WA, Post Falls ID,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT07200830
Phase 3, Recruiting
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
for
Anaplastic Large Cell Lymphoma, ALK-Negative,
Location: Portland OR, Clackamas OR, Vancouver WA, Oregon City OR,
Sponsor: Eastern Cooperative Oncology Group
Sex: All
Age: 18 - 70+
Code: NCT06724237
Phase 3, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma